Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier
- Vol. 20 (6) , 702-706
- https://doi.org/10.1016/s0168-8278(05)80138-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Sex hormone receptors in hepatocellular carcinoma (HCC). Is there a rationale for hormonal treatment?Journal of Hepatology, 1991
- Progesterone receptor in hepatocellular carcinoma. Correlation with androgen and estrogen receptorsCancer, 1991
- Estrogen receptors, progesterone receptors and heat-shock 27-kD protein in liver biopsy specimens from patients with hepatitis B virus infectionHepatology, 1991
- Hormonal manipulation of human hepatocellular carcinoma: A clinical investigative and therapeutic opportunityJournal of Hepatology, 1990
- Clinicopathologic Comparisons Between Estrogen Receptor-positive and -negative Hepatocellular CarcinomasAnnals of Surgery, 1990
- The effect of estrogen and tamoxifen on hepatocyte proliferation in Vivo and in VitroHepatology, 1989
- Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in womenCancer, 1989
- Hepatic estrogen receptor in human liver diseaseGastroenterology, 1987
- Oral contraceptives and hepatocellular carcinoma.BMJ, 1986
- Androgen and estrogen receptors in hepatocellular carcinoma and in the surrounding noncancerous liver tissueHepatology, 1986